Free Home Shipping
Ready to Soothe
Our T*C inhaler is designed to provide near-instant relief from aches, pains and stress and to stimulate appetite.
Order NowOur T*C inhaler is designed to provide near-instant relief from aches, pains and stress and to stimulate appetite.
Order Now
Not satisfied after 30 days? No problem. Email us at returns@eo.care and we’ll refund your money.
Order Now
Relief is felt within 1-2 minutes. Great for anytime use or when symptoms spike.
Each inhale delivers a predictable, metered dose of 0.25mg T*C.
There’s no odor. And you can finally say goodbye to smoking and vaping.
EO is recommended by clinicians at leading healthcare centers, including Mayo Clinic, Mt Sinai Hospital, Northwell Health, Penn Medicine and UVA Health - as well as by leading older adult and cancer advocacy organizations.
This inhaler provides quick relief and is easy to use. Many appreciate its discreet, portable design that works well in various settings. Reviews frequently mention its rapid effectiveness. Common feedback also highlights its convenience and odorless operation.
Some users note it can be harsh and trigger coughing. Several suggest adding a dose counter feature. While many find the strength suitable, experienced users with high tolerances often request increased potency.
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
An internationally recognized cannabis clinician and educator, Dr Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
A pioneering palliative care clinician and researcher, Dr. Worster is currently Director, Supportive Oncology at Jefferson Health in Philadelphia. She is a graduate of Temple University School of Medicine and completed her fellowship in palliative care and pain management at MGH Brigham and Dana Farber Cancer Center in Boston.
An internationally recognized cannabis clinician and educator, Dr Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
An internationally recognized cannabis clinician and educator, Dr Caplan has overseen the care of over 18,000 cannabis patients and developed protocols that have benefited tens of thousands more. He is a graduate of Tufts University School of Medicine and completed his residency in family medicine at Boston Medical Center.
A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
A leading clinical geriatric pharmacist and educator, Dr. Hajjar serves as Professor and Director of the Population Health Pharmacy Program at the Jefferson College of Pharmacy. She received her PharmD at Duquesne University and completed a fellowship in Geriatric Pharmacoepidemiology at the University of Minnesota.
To this end, we’ve attracted a team of committed investors and advisors, including Bill Van Faasen, former CEO of Blue Cross Blue Shield Massachusetts, Kristi Savacool, former CEO of Aon Hewitt and Dr. Regina Benjamin, former US Surgeon General.
